760 related articles for article (PubMed ID: 32459524)
1. Obesity and COVID-19: immune and metabolic derangement as a possible link to adverse clinical outcomes.
Korakas E; Ikonomidis I; Kousathana F; Balampanis K; Kountouri A; Raptis A; Palaiodimou L; Kokkinos A; Lambadiari V
Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E105-E109. PubMed ID: 32459524
[TBL] [Abstract][Full Text] [Related]
2. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
[TBL] [Abstract][Full Text] [Related]
3. Targeting the NLRP3 Inflammasome in Severe COVID-19.
Freeman TL; Swartz TH
Front Immunol; 2020; 11():1518. PubMed ID: 32655582
[TBL] [Abstract][Full Text] [Related]
4. Possible mechanisms responsible for acute coronary events in COVID-19.
Sheth AR; Grewal US; Patel HP; Thakkar S; Garikipati S; Gaddam J; Bawa D
Med Hypotheses; 2020 Oct; 143():110125. PubMed ID: 32763657
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms.
Raucci F; Mansour AA; Casillo GM; Saviano A; Caso F; Scarpa R; Mascolo N; Iqbal AJ; Maione F
Autoimmun Rev; 2020 Jul; 19(7):102572. PubMed ID: 32376393
[No Abstract] [Full Text] [Related]
6. Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19.
Luo W; Li YX; Jiang LJ; Chen Q; Wang T; Ye DW
Trends Pharmacol Sci; 2020 Aug; 41(8):531-543. PubMed ID: 32580895
[TBL] [Abstract][Full Text] [Related]
7. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.
Kempuraj D; Selvakumar GP; Ahmed ME; Raikwar SP; Thangavel R; Khan A; Zaheer SA; Iyer SS; Burton C; James D; Zaheer A
Neuroscientist; 2020; 26(5-6):402-414. PubMed ID: 32684080
[TBL] [Abstract][Full Text] [Related]
8. Severe COVID-19: NLRP3 Inflammasome Dysregulated.
van den Berg DF; Te Velde AA
Front Immunol; 2020; 11():1580. PubMed ID: 32670297
[TBL] [Abstract][Full Text] [Related]
9. [The endocrine and metabolic link between COVID-19, diabetes and obesity].
Weis N; Thorsteinsson K; Martinussen C; Madsbad S
Ugeskr Laeger; 2020 Jul; 182(29):. PubMed ID: 32734864
[TBL] [Abstract][Full Text] [Related]
10. The Collision of Meta-Inflammation and SARS-CoV-2 Pandemic Infection.
Huizinga GP; Singer BH; Singer K
Endocrinology; 2020 Nov; 161(11):. PubMed ID: 32880654
[TBL] [Abstract][Full Text] [Related]
11. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
Front Immunol; 2020; 11():581338. PubMed ID: 33123167
[TBL] [Abstract][Full Text] [Related]
12. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052
[TBL] [Abstract][Full Text] [Related]
13. The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of "inflame-aging".
Meftahi GH; Jangravi Z; Sahraei H; Bahari Z
Inflamm Res; 2020 Sep; 69(9):825-839. PubMed ID: 32529477
[TBL] [Abstract][Full Text] [Related]
14. Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response.
Cunha LL; Perazzio SF; Azzi J; Cravedi P; Riella LV
Front Immunol; 2020; 11():1748. PubMed ID: 32849623
[TBL] [Abstract][Full Text] [Related]
15. Is a "Cytokine Storm" Relevant to COVID-19?
Sinha P; Matthay MA; Calfee CS
JAMA Intern Med; 2020 Sep; 180(9):1152-1154. PubMed ID: 32602883
[No Abstract] [Full Text] [Related]
16. Natural Killer Cell Dysfunction and Its Role in COVID-19.
van Eeden C; Khan L; Osman MS; Cohen Tervaert JW
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32883007
[TBL] [Abstract][Full Text] [Related]
17. The laboratory tests and host immunity of COVID-19 patients with different severity of illness.
Wang F; Hou H; Luo Y; Tang G; Wu S; Huang M; Liu W; Zhu Y; Lin Q; Mao L; Fang M; Zhang H; Sun Z
JCI Insight; 2020 May; 5(10):. PubMed ID: 32324595
[TBL] [Abstract][Full Text] [Related]
18. Emerging role of IL-6 and NLRP3 inflammasome as potential therapeutic targets to combat COVID-19: Role of lncRNAs in cytokine storm modulation.
Paniri A; Akhavan-Niaki H
Life Sci; 2020 Sep; 257():118114. PubMed ID: 32693241
[TBL] [Abstract][Full Text] [Related]
19. Immune Response and COVID-19: A mirror image of Sepsis.
López-Collazo E; Avendaño-Ortiz J; Martín-Quirós A; Aguirre LA
Int J Biol Sci; 2020; 16(14):2479-2489. PubMed ID: 32792851
[TBL] [Abstract][Full Text] [Related]
20. COVID-19: Proposing a Ketone-Based Metabolic Therapy as a Treatment to Blunt the Cytokine Storm.
Bradshaw PC; Seeds WA; Miller AC; Mahajan VR; Curtis WM
Oxid Med Cell Longev; 2020; 2020():6401341. PubMed ID: 33014275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
